Keywords: immupharma, joins, london, aim, uk, drug, discovery

ImmuPharma joins London's AIM

Article | 30 January 2006

Print This

ImmuPharma, a UK drug discovery and development company focusing on the treatment of serious medical conditions such as Lupus, cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in